You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

moderate essential hypertension

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Essential Hypertension Trial in China (SPH3127 tablet, Valsartan)

Recruiting
  • Essential Hypertension
  • Beijing, Beijing, China
  • +13 more
May 4, 2022

Essential Hypertension Trial in Shenzhen (Sacubatril Allisartan medoxomil, Olmesartan Medoxomil)

Recruiting
  • Essential Hypertension
  • Sacubatril Allisartan medoxomil
  • Olmesartan Medoxomil
  • Shenzhen, Guangdong, China
    Shenzhen People' S Hospital
Aug 30, 2021

Hypertension Trial (MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks)

Completed
  • Hypertension
  • MK0954A, hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 Weeks
  • (no location specified)
Feb 7, 2022

Hypertension Trial (Losartan 50 mg / HCTZ 12.5 mg)

Completed
Has Results
  • Hypertension
  • Losartan 50 mg / HCTZ 12.5 mg
  • (no location specified)
Feb 7, 2022

Hypertension,Essential Trial in China (SPH3127 tablet Dose 1, SPH3127 tablet Dose 2, SPH3127 tablet Dose 3)

Completed
  • Hypertension,Essential
  • SPH3127 tablet Dose 1
  • +3 more
  • Beijing, China
  • +9 more
Nov 11, 2021

Essential Hypertension Trial (AZM X mg + AML Y mg, AZM X mg + AML Y' mg, AZM X' mg + AML Y mg)

Not yet recruiting
  • Essential Hypertension
  • AZM X mg + AML Y mg
  • +7 more
  • (no location specified)
May 25, 2022

Hypertension Trial in Tokyo (SPP100 (aliskiren))

Completed
  • Hypertension
  • SPP100 (aliskiren)
  • Tokyo, Japan
    Novartis Investigative Site
Dec 17, 2020

S-amlodipine in Essential HypertensIon and Assessment of Blood

Recruiting
  • Essential Hypertension
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      Bundang Seoul University Hospital
    Nov 8, 2023

    Essential Hypertension, Primary Hypertension Trial (Amicomed®, Digital Placebo, Usual Care)

    Not yet recruiting
    • Essential Hypertension
    • Primary Hypertension
    • Amicomed®
    • +2 more
    • (no location specified)
    Oct 19, 2023

    Aerobic Exercise in Patients With Essential Hypertension

    Completed
    • Aerobic Exercise
    • Essential Hypertension
    • Supervised Aerobic Exercise
    • Konya, Turkey
      Selcuk University Faculty of Medicine
    Aug 3, 2023

    Essential Hypertension Trial in Changchun (Remote ischemic conditioning, Sham remote ischemic conditioning)

    Not yet recruiting
    • Essential Hypertension
    • Remote ischemic conditioning
    • Sham remote ischemic conditioning
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Jun 15, 2023

    Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)

    Not yet recruiting
    • Essential Hypertension
    • NW Roselle
    • Captopril 25Mg Tab
    • (no location specified)
    Nov 15, 2023

    Essential Hypertension Trial (Nerkardou 5 mg & Nerkardou 10 mg)

    Not yet recruiting
    • Essential Hypertension
    • Nerkardou 5 mg & Nerkardou 10 mg
    • (no location specified)
    May 30, 2023

    Essential Hypertension Trial in Giza (dynamic neuromuscular stabilization training, balance exercises plus diaphragmatic

    Not yet recruiting
    • Essential Hypertension
    • dynamic neuromuscular stabilization training
    • balance exercises plus diaphragmatic breathing
    • Giza, Egypt
      Faculty of Physical Therapy
    Jun 14, 2023

    Uncontrolled Essential Hypertension Trial in Chongqing, Harbin (disposable intravascular ultrasound ablation catheter and

    Recruiting
    • Uncontrolled Essential Hypertension
    • disposable intravascular ultrasound ablation catheter and ultrasound ablation instrument
    • Chongqing, China
    • +1 more
    Mar 21, 2023

    Essential Hypertension Trial in Riyadh (Slow Breathing Exercise (SBE), Progressive Muscle Relaxation (PMR) Technique)

    Completed
    • Essential Hypertension
    • Slow Breathing Exercise (SBE)
    • Progressive Muscle Relaxation (PMR) Technique
    • Riyadh, Riyadh 11433, Saudi Arabia
      Rehabilitation Research Chair, Department of Rehabilitation Scie
    Jan 13, 2023

    Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)

    Not yet recruiting
    • Essential Hypertension
    • Primary Hypercholesterolemia
    • Seoul, Korea, Republic of
      Severance Hospital
    Jun 26, 2023

    Essential Hypertension Trial in Changchun (Remote ischemic conditioning, Sham remote ischemic conditioning)

    Not yet recruiting
    • Essential Hypertension
    • Remote ischemic conditioning
    • Sham remote ischemic conditioning
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Apr 26, 2023

    Hypertension, Blood Pressure, Cardiovascular Diseases Trial in Nanjing, Suzhou (focused power ultrasound mediate inferior

    Not yet recruiting
    • Hypertension
    • +2 more
    • focused power ultrasound mediate inferior perirenal adipose tissue modification
    • sham-control group
    • Nanjing, Jiangsu, China
    • +2 more
    Aug 29, 2023

    Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine

    Not yet recruiting
    • Essential Hypertension
    • Azilsartan Medoxomil Potassium Tablet
    • +2 more
    • (no location specified)
    Jul 21, 2023

    Essential Hypertension Trial in Seoul (D064 and D702, QD, D064 and Placebo of D702, QD, Placebo of D064 and D702, QD)

    Recruiting
    • Essential Hypertension
    • D064 and D702, QD
    • +2 more
    • Seoul, Seongdong-gu, Korea, Republic of
      Hanyang University Seoul Hospital
    Nov 7, 2023

    Essential Hypertension Trial in Changchun (Remote Ischemic Conditioning)

    Not yet recruiting
    • Essential Hypertension
    • Remote Ischemic Conditioning
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Oct 31, 2022

    Hypertension,Essential Trial in Copenhagen (Training)

    Completed
    • Hypertension,Essential
    • Training
    • Copenhagen, Denmark
      University of Copenhagen
    Nov 1, 2022

    Hypertension, Hypertension, Essential Trial in Nashville (Angiotensin (1-7), Trimethaphan, Phenylephrine)

    Active, not recruiting
    • Hypertension
    • Hypertension, Essential
    • Angiotensin (1-7)
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University
    Jan 2, 2023

    Essential Hypertension, Diabetes, Type 2 Trial in Seongnam (ATB-1011, ATB-1012, ATB-1013)

    Recruiting
    • Essential Hypertension
    • Diabetes Mellitus, Type 2
    • Seongnam, Gyeonggi, Korea, Republic of
      Seoul National University Bundang Hospital
    Jan 31, 2023